American journal of nephrology · 2026
Diagnostic Utility of NT-proBNP in Tracking Cardiovascular Functional and Structural Changes in Advanced CKD and Post-Transplantation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Campos Monique, Groninger Nolan, Narayanan Gayatri, Tomkins Claudia, Burney Heather N, Li Xiaochun, Carlton Olivia, Chen Stone, Ting Stephen M S, Zehnder Daniel, Hiemstra Thomas, Lim Kenneth
Аннотация
INTRODUCTION: NT-proBNP is a critical biomarker in the management of heart failure. However, its role in tracking cardiovascular (CV) function and structure in patients with advanced chronic kidney disease (CKD) and after kidney transplantation remains unclear. Herein, we investigated the association between NT-proBNP with CV function and structure in advanced CKD and longitudinally post-kidney transplantation.
METHODS: We assessed 159 stage 5 CKD patients from the Cardiopulmonary Exercise Testing in Renal Failure and After Kidney Transplantation (CAPER) cohort, including kidney transplant recipients (KTRs) and waitlisted controls (NTWCs). All patients underwent cardiopulmonary exercise testing and echocardiography at baseline and 1-year follow-up and were stratified by baseline NT-proBNP quartiles (Q1-Q4).
RESULTS: Groups were balanced by sex and race (p > 0.05); however, Q4 patients were older, had lower BMI, and were predominantly on hemodialysis (all p < 0.03). Higher baseline NT-proBNP was associated with lower VO2Max (gold-standard index of CV functional capacity), reduced peak HR, workload, endurance time, and elevated LVMI (all p < 0.007). Longitudinally, NTWCs demonstrated worsening VO2Max, workload, peak HR, and endurance time, along with a mean 89% increase in NT-proBNP. In KTRs, VO2Max, workload, and endurance time improved in parallel with a mean 92% reduction in NT-proBNP after transplantation (all p ≤ 0.02). Changes in logNT-proBNP before and after transplantation were associated with alterations in VO2Max, peak HR, workload, and elevated LVMI (all p < 0.02).
CONCLUSION: Elevated NT-proBNP reflects impaired CV function and structure in advanced CKD and may serve as a prognostic biomarker for tracking improvements in CV health in patients with advanced CKD and undergoing kidney transplantation.
METHODS: We assessed 159 stage 5 CKD patients from the Cardiopulmonary Exercise Testing in Renal Failure and After Kidney Transplantation (CAPER) cohort, including kidney transplant recipients (KTRs) and waitlisted controls (NTWCs). All patients underwent cardiopulmonary exercise testing and echocardiography at baseline and 1-year follow-up and were stratified by baseline NT-proBNP quartiles (Q1-Q4).
RESULTS: Groups were balanced by sex and race (p > 0.05); however, Q4 patients were older, had lower BMI, and were predominantly on hemodialysis (all p < 0.03). Higher baseline NT-proBNP was associated with lower VO2Max (gold-standard index of CV functional capacity), reduced peak HR, workload, endurance time, and elevated LVMI (all p < 0.007). Longitudinally, NTWCs demonstrated worsening VO2Max, workload, peak HR, and endurance time, along with a mean 89% increase in NT-proBNP. In KTRs, VO2Max, workload, and endurance time improved in parallel with a mean 92% reduction in NT-proBNP after transplantation (all p ≤ 0.02). Changes in logNT-proBNP before and after transplantation were associated with alterations in VO2Max, peak HR, workload, and elevated LVMI (all p < 0.02).
CONCLUSION: Elevated NT-proBNP reflects impaired CV function and structure in advanced CKD and may serve as a prognostic biomarker for tracking improvements in CV health in patients with advanced CKD and undergoing kidney transplantation.